Atlas Trials

Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect

Clinical trial NCT00988494 · COMPLETED

Trial details

NCT number
NCT00988494
Sponsor
Santen Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Persistent Corneal Epithelial Defect
Start date
2009-09-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.